{"transactions":[{"id":2605004,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104416,"kind":"organization","name":"BC SW, LP","position":2,"cik":"0001786351","reported_name":"BC SW, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75682,"kind":"person","name":"Schwartz Jeffrey Lawrence","position":3,"cik":"0001702957","reported_name":"Schwartz Jeffrey Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51911,"kind":"person","name":"Koppel Adam","position":4,"cik":"0001578965","reported_name":"Koppel Adam","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-13T00:38:04.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":1000000,"price":70.25,"value":70250000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares of common stock held directly by BC SW, LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, LP. As a result, each of BCLSI, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, LP. BCLSI, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of its or their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Jeffrey Schwartz is a director of the Issuer."}],"balance_after":4831307,"source":{"system":"sec-edgar","filing":"0000899243-21-032893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578965/000089924321032893/doc4.xml","form_type":"4"}},{"id":2794103,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104416,"kind":"organization","name":"BC SW, LP","position":2,"cik":"0001786351","reported_name":"BC SW, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75682,"kind":"person","name":"Schwartz Jeffrey Lawrence","position":3,"cik":"0001702957","reported_name":"Schwartz Jeffrey Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51911,"kind":"person","name":"Koppel Adam","position":4,"cik":"0001578965","reported_name":"Koppel Adam","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T21:30:16.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":1450000,"price":71.5,"value":103675000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares of common stock held directly by BC SW, LP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bain Capital Life Sciences Investors, LLC (\"BCLSI\"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, LP. As a result, each of BCLSI, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, LP. BCLSI, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Schwartz is a director of the Issuer."}],"balance_after":5831307,"source":{"system":"sec-edgar","filing":"0000899243-21-011153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578965/000089924321011153/doc4.xml","form_type":"4"}},{"id":3409667,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104416,"kind":"organization","name":"BC SW, LP","position":2,"cik":"0001786351","reported_name":"BC SW, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75682,"kind":"person","name":"Schwartz Jeffrey Lawrence","position":3,"cik":"0001702957","reported_name":"Schwartz Jeffrey Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51911,"kind":"person","name":"Koppel Adam","position":4,"cik":"0001578965","reported_name":"Koppel Adam","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-09-19T23:05:35.000Z","date":"2019-09-17","kind":"exercise","acquired":false,"shares":1053204,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series B Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series B Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series B Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by BC SW, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Life Sciences Investors, LLC (\"BCI LS\"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, L.P. As a result, each of BCI LS, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, L.P. BCI LS, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Jeffrey Schwartz is a director of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1053204},"source":{"system":"sec-edgar","filing":"0000899243-19-023936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1578965/000089924319023936/doc4.xml","form_type":"4"}},{"id":3409666,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104416,"kind":"organization","name":"BC SW, LP","position":2,"cik":"0001786351","reported_name":"BC SW, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75682,"kind":"person","name":"Schwartz Jeffrey Lawrence","position":3,"cik":"0001702957","reported_name":"Schwartz Jeffrey Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51911,"kind":"person","name":"Koppel Adam","position":4,"cik":"0001578965","reported_name":"Koppel Adam","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-09-19T23:05:35.000Z","date":"2019-09-17","kind":"exercise","acquired":false,"shares":6078103,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series A Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series A Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series A Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series A Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by BC SW, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Life Sciences Investors, LLC (\"BCI LS\"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, L.P. As a result, each of BCI LS, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, L.P. BCI LS, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Jeffrey Schwartz is a director of the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6078103},"source":{"system":"sec-edgar","filing":"0000899243-19-023936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1578965/000089924319023936/doc4.xml","form_type":"4"}},{"id":3409665,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104416,"kind":"organization","name":"BC SW, LP","position":2,"cik":"0001786351","reported_name":"BC SW, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75682,"kind":"person","name":"Schwartz Jeffrey Lawrence","position":3,"cik":"0001702957","reported_name":"Schwartz Jeffrey Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51911,"kind":"person","name":"Koppel Adam","position":4,"cik":"0001578965","reported_name":"Koppel Adam","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T23:05:35.000Z","date":"2019-09-17","kind":"purchase","acquired":true,"shares":150000,"price":18,"value":2700000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares purchased in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by BC SW, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Life Sciences Investors, LLC (\"BCI LS\"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, L.P. As a result, each of BCI LS, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, L.P. BCI LS, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Jeffrey Schwartz is a director of the Issuer."}],"balance_after":7281307,"source":{"system":"sec-edgar","filing":"0000899243-19-023936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1578965/000089924319023936/doc4.xml","form_type":"4"}},{"id":3409664,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104416,"kind":"organization","name":"BC SW, LP","position":2,"cik":"0001786351","reported_name":"BC SW, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75682,"kind":"person","name":"Schwartz Jeffrey Lawrence","position":3,"cik":"0001702957","reported_name":"Schwartz Jeffrey Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51911,"kind":"person","name":"Koppel Adam","position":4,"cik":"0001578965","reported_name":"Koppel Adam","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T23:05:35.000Z","date":"2019-09-17","kind":"exercise","acquired":true,"shares":1053204,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series B Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by BC SW, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Life Sciences Investors, LLC (\"BCI LS\"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, L.P. As a result, each of BCI LS, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, L.P. BCI LS, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Jeffrey Schwartz is a director of the Issuer."}],"balance_after":7131307,"source":{"system":"sec-edgar","filing":"0000899243-19-023936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1578965/000089924319023936/doc4.xml","form_type":"4"}},{"id":3409663,"issuer":{"id":15910,"kind":"organization","name":"SpringWorks Therapeutics, Inc.","symbol":"SWTX"},"owners":[{"id":44733,"kind":"organization","name":"Bain Capital Life Sciences Investors, LLC","position":1,"cik":"0001703031","reported_name":"Bain Capital Life Sciences Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":104416,"kind":"organization","name":"BC SW, LP","position":2,"cik":"0001786351","reported_name":"BC SW, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75682,"kind":"person","name":"Schwartz Jeffrey Lawrence","position":3,"cik":"0001702957","reported_name":"Schwartz Jeffrey Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":51911,"kind":"person","name":"Koppel Adam","position":4,"cik":"0001578965","reported_name":"Koppel Adam","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-09-19T23:05:35.000Z","date":"2019-09-17","kind":"exercise","acquired":true,"shares":6078103,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock was convertible into shares of the Issuer's Common Stock on a 6.5810:1 basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Convertible Preferred Stock automatically converted into shares of Common Stock of the Issuer. The Series A Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by BC SW, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Bain Capital Life Sciences Investors, LLC (\"BCI LS\"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, L.P. As a result, each of BCI LS, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, L.P. BCI LS, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Jeffrey Schwartz is a director of the Issuer."}],"balance_after":6078103,"source":{"system":"sec-edgar","filing":"0000899243-19-023936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578965/000089924319023936/doc4.xml","form_type":"4"}}]}